Drug Shortage Report for THIAMIJECT INJECTION - LIQ IM IV 100MG/ML

Last updated on 2023-02-24 History
Report ID 182152
Drug Identification Number 02193221
Brand name THIAMIJECT INJECTION - LIQ IM IV 100MG/ML
Common or Proper name THIAMINE HYDROCHLORIDE INJECTION 100MG/ML
Company Name OMEGA LABORATORIES LIMITED
Market Status MARKETED
Active Ingredient(s) THIAMINE HYDROCHLORIDE
Strength(s) 100MG
Dosage form(s) LIQUID
Route of administration INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR
Packaging size 5 x 10mL vial / fiole
ATC code A11DA
ATC description VIT B1,PLAIN AND IN COMB WITH VITAMIN B6 AND B12
Reason for shortage Demand increase for the drug.
Anticipated start date 2023-01-30
Actual start date 2023-01-27
Estimated end date 2023-02-23
Actual end date 2023-02-23
Shortage status Resolved
Updated date 2023-02-24
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 11177 HAMON
MONTREAL, QUEBEC
CANADA H3M 3E4
Company contact information info@omegalaboratory.com - 1-800-363-0584

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2023-02-24 English Compare
v9 2023-02-23 French Compare
v8 2023-02-23 English Compare
v7 2023-02-03 French Compare
v6 2023-02-03 English Compare
v5 2023-01-28 English Compare
v4 2023-01-27 French Compare
v3 2023-01-27 English Compare
v2 2023-01-20 French Compare
v1 2023-01-20 English Compare

Showing 1 to 10 of 10